Monkeypox Diagnostic Testing Launched by US BioTek
US BioTek Laboratories is now offering Monkeypox Diagnostic Testing, utilizing a lesion swap specimen and RT-PCR testing.
Read MorePosted by Chris Wolski | Oct 14, 2022 | Emerging & Zoonotic Diseases, Immunoassay Reagents & test Kits |
US BioTek Laboratories is now offering Monkeypox Diagnostic Testing, utilizing a lesion swap specimen and RT-PCR testing.
Read MorePosted by Chris Wolski | Oct 14, 2022 | Allergy & Autoimmune |
T2 Biosystems plans to commercialize, a diagnostic test for early Lyme disease, with a goal of releasing it in the U.S. as an LDT in 2023.
Read MorePosted by Chris Wolski | Oct 13, 2022 | Gastrointestinal Infections |
Researchers have created a method that makes sewage monitoring possible for a virus that may be linked to hepatitis outbreaks worldwide.
Read MorePosted by Chris Wolski | Oct 10, 2022 | Prenatal Testing |
Diagnostic screening for Down’s Syndrome during pregnancy was difficult until the development of an NIPT fetal fraction test.
Read MorePosted by Bryce Lochmann | Oct 10, 2022 | Disease States |
Multiplex testing offers labs a way to conclusively efficiently, and cost effectively diagnose patients presenting with symptoms that could be COVID or flu, cutting time to diagnosis and improving time to treatment.
Read More